Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the drug eluting stent market grown in recent years?
The drug-eluting stent market has seen strong growth in recent years. It is expected to increase from $7.63 billion in 2024 to $8.29 billion in 2025, with a CAGR of 8.6%. The market’s growth is attributed to the need for better treatment options, supporting clinical evidence, regulatory approvals, healthcare economics, and evolving guidelines.
How is the drug eluting stent market size expected to evolve during the forecast period?
The drug-eluting stent market is expected to grow to $11.37 billion by 2029, with a CAGR of 8.2%. This growth is driven by an aging population, the expansion of medical indications, favorable healthcare policies, global market expansion, and patient-centered care. Trends include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.
Get your drug eluting stent market report here!
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report
Which key drivers are propelling the drug eluting stent market’s growth?
The increasing prevalence of coronary heart disease is expected to drive the growth of the drug-eluting stent market. Coronary heart disease (CHD) occurs when the coronary arteries become blocked or narrowed due to plaque buildup, leading to severe complications like heart attacks or chest pain. CHD is on the rise due to factors such as sedentary lifestyles, poor diets, aging populations, and increased awareness. Drug-eluting stents (DES) help by reopening narrowed arteries and releasing medication to prevent re-narrowing (restenosis). For example, in May 2024, the Centers for Disease Control and Prevention reported that the percentage of adults aged 18 and over with CHD increased from 4.6% in 2020 to 4.9% in 2022, which is expected to drive the drug-eluting stent market.
What are the market segments in the drug eluting stent industry?
The drug eluting stent market covered in this report is segmented –
1) By Product: Polymer-Based, Polymer-Free
2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs
3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds
4) By Application: Coronary Diseases, Peripheral Vascular Diseases
5) By End-User: Hospitals, Specialty Clinic
Subsegments:
1) By Polymer-Based: Durable Polymer Drug-Eluting Stents, Biodegradable Polymer Drug-Eluting Stents
2) By Polymer-Free: Bare-Metal Stents With Drug Coating, Other Polymer-Free Drug-Eluting Stents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp
Which leading companies are shaping the growth of the drug eluting stent market?
Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.
What key trends are currently impacting the drug eluting stent market’s development?
Companies in the drug-eluting stent market are focusing on enhancing delivery systems like the dual-layer balloon to improve patient outcomes. This system improves the accuracy of drug delivery and stent deployment, ensuring even drug distribution along the arterial wall. Medtronic Plc launched Onyx Frontier in August 2022, a new generation of drug-eluting coronary stents that builds on the performance and data of its predecessor, Resolute Onyx DES. Onyx Frontier DES offers advancements such as a dual-layer balloon, a smaller crossing profile, and better catheter flexibility, boosting deliverability by 16% compared to the earlier model, all while maintaining radial strength.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15557
Which geographic areas are influencing the growth of the drug eluting stent market?
North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Consumer Electronics Repair and Maintenance Global Market Report 2024
Authorized Car Service Center Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/authorized-car-service-center-global-market-report
Maintenance Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
